Changes in the assessments of cancer service
indicators in cervical cancer in Kazakhstan
About 800 thousand new cases of cervical cancer (CC) are predicted, and it is expected that about 460 thousand women will die from this pathology, according to the forecasts of the International Agency for Research on Cancer in 2040. To this aim, an analysis studying the indicators of the cancer service for CC also allows us to evaluate the effectiveness of anti-cancer measures in the Republic of Kazakhstan. Aim: Evaluate some indicators of the cancer service at CC in Kazakhstan for 2009-2018. Materials and methods. The research material was data from the Ministry of Health of the Republic of Kazakhstan – annual form No.7 and 35 regarding CC (ICD10–C53) for 2009-2018 – incidence, mortality, early diagnosis, neglect, morphological verification. A retrospective study using descriptive and analytical methods of biomedical statistics was used as the main method. Results and discussion. For 2009-2018, 16,441 new cases of CC were registered in the Republic for the first time, and 6,461 women died from this disease. The crude CC incidence rate increased from 16.3±0.4‰ (2009) to 19.5±0.5‰ in 2018 (p=0.000). In dynamics, mortality rates from CC tended to decrease from 8.4±0.3‰ (2009) to 6.4±0.3‰ in 2018 (р=0.000). The research of the study period reveals a trend: early diagnosis indicators (specific weight of patients with I-II stage) improved from 79.8% (2009) to 88.1% in 2018, and accordingly the specific weight of neglected patients significantly decreased with stage III (from 15.4% to 8.9%) and with stage IV (from 3.4% to 2.7%). The morphological verification indicators for CC remained virtually unchanged, remaining fairly high 99.2% and 99.3%, respectively, in 2009 and 2018. Conclusion. An analysis of the indicators of the cancer service in CC revealed an improvement in morphological verification and early diagnosis, a decrease in neglect and mortality rates, which is undoubtedly associated with regular anti-cancer activities in Kazakhstan, in particular CC screening.